Indivior PLC ORD USD0.10

(LSE, Stocks) 
p 366.20
Updated 22/06/2018
Change % 0.00% Stock price unchanged
Change 0.00 Stock price unchanged
Volume 4,346,675
High P 366.50
Low P 358.20
Open P 360.70
Prev close P 361.00
# of shares 728.10M
Market cap 266,632M GBX

Market closed
Indivior PLC ORD USD0.10
Market is closed, opens at 08:00
Price development Latest 1 week 1 month 3 months 6 months 1 year
  366.20 1.6% Stock price increasing -22.5% Stock price decreasing -4.3% Stock price decreasing -8.9% Stock price decreasing 9.9% Stock price increasing
Powered by TradingView

Company profile

Indivior PLC is a specialty and generic drug manufacturing company. The company is focused on the development, manufacture, and sale of prescription drugs based on buprenorphine for treatment of opioid dependence. The vast majority of Indivior's revenue is generated in the United States, followed by the rest of the world. The company considers merger and acquisition investment to be a potential component of its operational growth strategy for expanding its research, development, manufacturing, and marketing capabilities.

Copyright Euroinvestor A/S 2018   Disclaimer and Terms of Use
Quote information is delivered by Morningstar.
Data is delayed 15-20 minutes according to the distribution agreements set by the different exchanges.
24 June 2018 05:55:50
(UTC+00:00) Dublin, Edinburgh, Lisbon, London
Version: LiveBranchBuild_20180619.1 - EUROWEB3 - 2018-06-24 06:55:50 - 2018-06-24 05:55:50 - 1000 - Website: OKAY